These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 110689)
21. Type-specific indirect hemagglutinating antibody in patients with Pseudomonas aeruginosa Infection. Shigeta S; Yasunaga Y; Ogata M J Clin Microbiol; 1978 Nov; 8(5):489-95. PubMed ID: 103887 [TBL] [Abstract][Full Text] [Related]
22. Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa. Hassan R; El-Naggar W; Abd El-Aziz AM; Shaaban M; Kenawy HI; Ali YM J Microbiol Immunol Infect; 2018 Jun; 51(3):312-320. PubMed ID: 28291719 [TBL] [Abstract][Full Text] [Related]
24. Effector mechanisms of protection against Pseudomonas aeruginosa keratitis in immunized rats. Thakur A; Kyd J; Xue M; Willcox MD; Cripps A Infect Immun; 2001 May; 69(5):3295-304. PubMed ID: 11292752 [TBL] [Abstract][Full Text] [Related]
25. Immunization with Pseudomonas aeruginosa vaccines and adjuvant can modulate the type of inflammatory response subsequent to infection. Johansen HK; Espersen F; Cryz SJ; Hougen HP; Fomsgaard A; Rygaard J; Høiby N Infect Immun; 1994 Aug; 62(8):3146-55. PubMed ID: 8039883 [TBL] [Abstract][Full Text] [Related]
26. Flagellin and pilin immunization against multi-drug resistant Pseudomonas aeruginosa protects mice in the burn wound sepsis model. Korpi F; Hashemi FB; Irajian G; Fatemi MJ; Laghaei P; Behrouz B Immunol Lett; 2016 Aug; 176():8-17. PubMed ID: 27210422 [TBL] [Abstract][Full Text] [Related]
27. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection. Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605 [TBL] [Abstract][Full Text] [Related]
28. Enhancement of experimental bacteremia and endocarditis caused by dysgonic fermenter (DF-2) bacterium after treatment with methylprednisolone and after splenectomy. Butler T; Johnston KH; Gutierrez Y; Aikawa M; Cardaman R Infect Immun; 1985 Jan; 47(1):294-300. PubMed ID: 3965402 [TBL] [Abstract][Full Text] [Related]
29. Neutralizing antibody to Pseudomonas aeruginosa exotoxin in human sera: evidence for in vivo toxin production during infection. Pollack M; Callahan LT; Taylor NS Infect Immun; 1976 Oct; 14(4):942-7. PubMed ID: 825470 [TBL] [Abstract][Full Text] [Related]
30. Effectiveness of immunization with single and multi-component vaccines prepared from a common antigen (OEP), protease and elastase toxoids of Pseudomonas aeruginosa on protection against hemorrhagic pneumonia in mink due to P. aeruginosa. Homma JY; Abe C; Tanamoto K; Hirao Y; Morihara K; Tsuzuki H; Yanagawa R; Honda E; Aoi Y; Fujimoto Y; Goryo M; Imazeki N; Noda H; Goda A; Takeuchi S; Ishihara T Jpn J Exp Med; 1978 Apr; 48(2):111-33. PubMed ID: 101698 [TBL] [Abstract][Full Text] [Related]
31. Human monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal pseudomonas sepsis. Hemachandra S; Kamboj K; Copfer J; Pier G; Green LL; Schreiber JR Infect Immun; 2001 Apr; 69(4):2223-9. PubMed ID: 11254577 [TBL] [Abstract][Full Text] [Related]
32. Detection of Pseudomonas aeruginosa antigenemia in granulocytopenic rabbits by radiommunoassay. Kohler RB; Wheat LJ; White A J Clin Microbiol; 1980 Jul; 12(1):39-43. PubMed ID: 6775008 [TBL] [Abstract][Full Text] [Related]
33. Bactericidal interactions of a beta-lactam and beta-lactamase inhibitors in experimental Pseudomonas aeruginosa endocarditis caused by a constitutive overproducer of type Id beta-lactamase. Bayer AS; Selecky M; Babel K; Hirano L; Yih J; Parr TR Antimicrob Agents Chemother; 1987 Nov; 31(11):1750-5. PubMed ID: 3124738 [TBL] [Abstract][Full Text] [Related]
34. Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection. Faezi S; Safarloo M; Amirmozafari N; Nikokar I; Siadat SD; Holder IA; Mahdavi M APMIS; 2014 Feb; 122(2):115-27. PubMed ID: 23758581 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of the immune responses following co-administration of PilQ and type b-flagellin from Pseudomonas aeruginosa in the burn mouse model. Bakht Azad S; Nikokar I; Faezi S; Rasooly S; Mahdavi M Microb Pathog; 2018 Oct; 123():426-432. PubMed ID: 30075242 [TBL] [Abstract][Full Text] [Related]
36. Common protective antigen between Pseudomanas aeruginosa and Vibrio cholerae. Yamamoto A; Homma JY; Ghoda A; Ishihara T; Takeuchi S Jpn J Exp Med; 1979 Dec; 49(6):383-90. PubMed ID: 120454 [TBL] [Abstract][Full Text] [Related]
37. Passive immunization against Pseudomonas aeruginosa recombinant PilA in a murine burn wound model. Mousavi M; Behrouz B; Irajian G; Mahdavi M; Korpi F; Motamedifar M Microb Pathog; 2016 Dec; 101():83-88. PubMed ID: 27836762 [TBL] [Abstract][Full Text] [Related]
38. Protective activity of immune sera against extracellular slime from Pseudomonas aeruginosa on experimental infection in mice. Sokalska M; Maresz-Babczyszyn J Arch Immunol Ther Exp (Warsz); 1981; 29(5):643-52. PubMed ID: 6812542 [TBL] [Abstract][Full Text] [Related]
39. A diphasic immune response against bacteria in the American cockroach. Faulhaber LM; Karp RD Immunology; 1992 Feb; 75(2):378-81. PubMed ID: 1551700 [TBL] [Abstract][Full Text] [Related]
40. Enzyme-linked immunosorbent assay for detection of Staphylococcus epidermidis antibody in experimental S. epidermidis endocarditis. Espersen F; Wheat LJ; Bemis AT; White A J Clin Microbiol; 1986 Feb; 23(2):339-42. PubMed ID: 3700616 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]